Company
PMV Pharmaceuticals, Inc. (PMVP)
Standardized SEC financial data for PMV Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001699382 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-74.2%
Free cash flow
-$73.6M
Current ratio
10.09×
EPS (diluted)
$-1.48
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $23.9M | $36.5M | $52.0M | $55.9M | $58.5M | $69.9M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $361.4M | $314.1M | $243.5M | $228.6M | $183.3M | $112.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$32.7M | -$46.6M | -$63.8M | -$55.7M | -$51.3M | -$73.6M |
| Capital expenditures |
Get PMVP data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PMVP/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PMVP/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"